NPPB and hydrops fetalis: To determine whether changes in NT-proBNP in patients treated with Sac/Val correlate with cardiac remodelling (indicated by LVESVi, LVEDVi, LVEF and LAVi), the PROVE-HF trial [78] was conducted.